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Liposomes entrapping magnetic nanoparticles (magnetoliposomes) are of large importance in drug delivery, 
as they can be guided and localized to the therapeutic site of interest by external magnetic field gradients and 
used in cancer treatment by hyperthermia [1,2].  
New fluorescent 1,3-diarylurea derivatives of thieno[3,2-b]pyridines (Fig.1), recently synthesized by us, 
have shown promising antitumoral activity in human tumor cell lines. Compounds 1a-c and 2a-c present 
very reasonable fluorescence quantum yields in several solvents (0.10 ≤ ΦF ≤ 0.50), but are not fluorescent in 
alcohols and water. 
In this work, magnetic nanoparticles of magnetite and of nickel core with silica shell were prepared by soft 
chemical methods and either covered with a lipid bilayer or entrapped in liposomes. The 1,3-diarylureas 1a-c 
and 2a-c were then encapsulated in liposomes and magnetoliposomes and their photophysical behavior was 
studied.  
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Figure 1. Structure of the compounds 1a-c and 2a-c.  Figure 2. Normalized fluorescence spectra of 1c in liposomes. 
Inset: Comparison between Egg-PC liposomes and 
magnetoliposomes.  
All compounds exhibit reasonable fluorescence emission when incorporated in liposomes (example of 1c in 
Fig. 2). Fluorescence anisotropy measurements indicate that these compounds can be transported in the 
hydrophobic region of the lipid bilayer. Incorporation in magnetoliposomes leads to an appreciable 
fluorescence quenching of the compounds by the entrapped magnetic nanoparticles. These results are 
promising for future drug delivery applications of these potential antitumoral compounds using 
magnetoliposomes.
Acknowledgements: FCT, FEDER, COMPETE/QREN/EU for financial support to CFUM (PEst-C/FIS/UI0607/2011) and CQ/UM 
(PEst-C/QUI/UI0686/2011) and to research projects PTDC/QUI/81238/2006 (FCOMP-01-0124-FEDER-007467), PTDC/QUI-
QUI/111060/2009 (FCOMP-01-0124-FEDER-015603). 
References: 
[1] A.S. Lubbe, C. Bergemann, J. Brock, D.G. McClure, J. Magn. Magn. Mater. 194 (1999) 149. 
[2] S. Dandamudi, R.B. Campbell, Biomaterials 28 (2007) 4673. 
